Russia's Ministry of Health has officially approved a new set of clinical guidelines that pathologize a range of non-normative sexual interests, including consensual BDSM and fetishism. The document, developed by the Russian Society of Psychiatrists, frames these interests as “disorders of sexual preference” and outlines methods for their diagnosis and treatment.
This marks the first time such a comprehensive document on the topic has been formally adopted in the country. While the guidelines also cover illegal acts like pedophilia, their inclusion of consensual activities under the same umbrella of mental disorder is a significant and concerning development.
What Qualifies as a 'Disorder'?
According to the guidelines, a diagnosis is not based solely on the presence of an 'atypical' sexual interest. For a person's preferences to be classified as a disorder, they must experience intense, long-term sexual urges or fantasies that are either acted upon or cause them “significant distress.” The framework also considers factors like consent and the risk of harm.
The list of conditions classified as “disorders of sexual preference” includes:
- Fetishism
- Sadomasochism (BDSM)
- Exhibitionism
- Voyeurism
- Pedophilia
The conflation of consensual activities like BDSM with non-consensual and criminal acts is a common tactic used to stigmatize sexual minorities and is in stark contrast to the understanding of sexual health in many Western countries, including the Netherlands.
A 'Cure' for Kink
The recommended treatment plan varies by the assessed “severity” of the disorder. For milder cases, psychotherapy, particularly cognitive-behavioral therapy (CBT), is suggested. However, for more pronounced cases, the guidelines recommend a combination of psychotherapy with pharmacological intervention.
This can include Selective Serotonin Reuptake Inhibitors (SSRIs), a common class of antidepressants, as well as hormonal drugs. The document specifically names anti-androgens and GnRH analogues—medications that suppress testosterone and reduce libido. The authors note that using these drugs for such purposes is often an 'off-label' application, requiring a special decision by a medical commission and the patient's informed consent.
A Chilling Context
This medical development does not exist in a vacuum. It arrives amidst an increasingly hostile environment for LGBTQ+ people in Russia. In late 2023, the country's Supreme Court designated the “international LGBT public movement” as an extremist organization, effectively outlawing any form of public LGBTQ+ activism.
By medicalizing consensual sexual practices that deviate from a narrow norm, these guidelines provide a new framework for social control. It creates a system where individuals can be labeled as mentally ill and subjected to 'treatment' for their identities and desires, reinforcing a state-sanctioned vision of acceptable sexuality. For the queer and kink communities in the Netherlands and beyond, it serves as a stark reminder of how medical institutions can be used to enforce social and political agendas.
